{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T07:12:41Z","timestamp":1778656361193,"version":"3.51.4"},"reference-count":85,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Antonio Meneghetti the Scientific and Humanistic Research Foundation"},{"name":"Malaysian Society of Haematology"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.critrevonc.2019.102818","type":"journal-article","created":{"date-parts":[[2019,11,2]],"date-time":"2019-11-02T23:58:08Z","timestamp":1572739088000},"page":"102818","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Clinical significance of aberrant microRNAs expression in predicting disease relapse\/refractoriness to treatment in diffuse large B-cell lymphoma: A meta-analysis"],"prefix":"10.1016","volume":"144","author":[{"given":"Choo-Yuen","family":"Ting","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Su-May","family":"Liew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy","family":"Price","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gin-Gin","family":"Gan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana","family":"Bee-Lan Ong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soo-Yong","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping-Chong","family":"Bee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.critrevonc.2019.102818_bib0005","doi-asserted-by":"crossref","first-page":"4125","DOI":"10.1158\/1078-0432.CCR-11-0224","article-title":"MicroRNAs are independent predictors of outcome in diffuse large B-cell lymphoma patients treated with R-CHOP","volume":"17","author":"Alencar","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2019.102818_bib0010","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.critrevonc.2019.04.013","article-title":"Cell-free DNA as a biomarker in diffuse large B-cell lymphoma: a systematic review","volume":"139","author":"Arzuaga-Mendez","year":"2019","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"2","key":"10.1016\/j.critrevonc.2019.102818_bib0015","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s12185-012-1256-x","article-title":"MicroRNA-21 regulates the sensitivity of diffuse large B-cell lymphoma cells to the CHOP chemotherapy regimen","volume":"97","author":"Bai","year":"2013","journal-title":"Int. J. Hematol."},{"issue":"2","key":"10.1016\/j.critrevonc.2019.102818_bib0020","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.febslet.2010.12.027","article-title":"Involvement of miR-21 in resistance to daunorubicin by regulating PTEN expression in the leukaemia K562 cell line","volume":"585","author":"Bai","year":"2011","journal-title":"FEBS Lett."},{"issue":"6","key":"10.1016\/j.critrevonc.2019.102818_bib0025","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1038\/jid.2015.27","article-title":"The high expression of the microRNA 17-92 cluster and its paralogs, and the downregulation of the target gene PTEN, is associated with primary cutaneous B-cell lymphoma progression","volume":"135","author":"Battistella","year":"2015","journal-title":"J. Invest. Dermatol."},{"issue":"3","key":"10.1016\/j.critrevonc.2019.102818_bib0030","first-page":"207","article-title":"Prognostic value of miRNA-155 expression in B-cell non-Hodgkin lymphoma","volume":"34","author":"Bedewy","year":"2017","journal-title":"Turk. J. Haematol."},{"issue":"2","key":"10.1016\/j.critrevonc.2019.102818_bib0035","doi-asserted-by":"crossref","first-page":"720","DOI":"10.3892\/or.2012.2173","article-title":"High expression of microRNA-200c predicts poor clinical outcome in diffuse large B-cell lymphoma","volume":"29","author":"Berglund","year":"2013","journal-title":"Oncol. Rep."},{"issue":"12","key":"10.1016\/j.critrevonc.2019.102818_bib0040","first-page":"1010","article-title":"Significance of microRNA-146b-5p in diffuse large B-cell lymphoma and its relationship with risk assessment","volume":"33","author":"Cao","year":"2012","journal-title":"Zhong hua xue ye xue za zhi= Zhong hua xue ye xue za zhi"},{"issue":"5","key":"10.1016\/j.critrevonc.2019.102818_bib0045","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/ejh.12263","article-title":"Clinical significance and detection of microRNA-21 in serum of patients with diffuse large B-cell lymphoma in Chinese population","volume":"92","author":"Chen","year":"2014","journal-title":"Eur. J. Haematol."},{"issue":"12","key":"10.1016\/j.critrevonc.2019.102818_bib0050","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1093\/carcin\/bgq192","article-title":"Oncogenic HER2\u039416 suppresses miR-15a\/16 and deregulates BCL-2 to promote endocrine resistance of breast tumors","volume":"31","author":"Cittelly","year":"2010","journal-title":"Carcinogenesis"},{"issue":"3","key":"10.1016\/j.critrevonc.2019.102818_bib0055","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1136\/jclinpath-2012-201021","article-title":"MicroRNAs are suitable for assessment as biomarkers from formalin-fixed paraffin-embedded tissue, and miR-24 represents an appropriate reference microRNA for diffuse large B-cell lymphoma studies","volume":"66","author":"Culpin","year":"2013","journal-title":"J. Clin. Pathol."},{"issue":"7","key":"10.1016\/j.critrevonc.2019.102818_bib0060","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1182\/bloodadvances.2018029660","article-title":"MicroRNA-155 controls vincristine sensitivity and predicts superior clinical outcome in diffuse large B-cell lymphoma","volume":"3","author":"Due","year":"2019","journal-title":"Blood Adv."},{"issue":"1","key":"10.1016\/j.critrevonc.2019.102818_bib0065","doi-asserted-by":"crossref","DOI":"10.4236\/ajmb.2017.71005","article-title":"The diagnostic and prognostic impact of serum miRNA-21 in a sample of hepatitis C\/none hepatitis diffuse large B cell lymphoma egyptian patients","volume":"7","author":"El-Halawani","year":"2017","journal-title":"Am. J. Mol. Biol."},{"issue":"11","key":"10.1016\/j.critrevonc.2019.102818_bib0070","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1182\/blood-2013-01-478222","article-title":"Prognostic value of miR-155 in individuals with monoclonal B-cell lymphocytosis and patients with B chronic lymphocytic leukemia","volume":"122","author":"Ferrajoli","year":"2013","journal-title":"Blood"},{"issue":"18","key":"10.1016\/j.critrevonc.2019.102818_bib0075","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1097\/BRS.0b013e3181b1c99f","article-title":"2009 updated method guidelines for systematic reviews in the Cochrane Back Review Group","volume":"34","author":"Furlan","year":"2009","journal-title":"Spine"},{"issue":"8","key":"10.1016\/j.critrevonc.2019.102818_bib0080","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1038\/bjc.2012.85","article-title":"Increased signalling of EGFR and IGF1R, and deregulation of PTEN\/PI3K\/Akt pathway are related with trastuzumab resistance in HER2 breast carcinomas","volume":"106","author":"Gallardo","year":"2012","journal-title":"Br. J. Cancer"},{"issue":"17","key":"10.1016\/j.critrevonc.2019.102818_bib0085","doi-asserted-by":"crossref","first-page":"15035","DOI":"10.18632\/oncotarget.3729","article-title":"MicroRNA-21 plays an oncogenic role by targeting FOXO1 and activating the PI3K\/AKT pathway in diffuse large B-cell lymphoma","volume":"6","author":"Go","year":"2015","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.critrevonc.2019.102818_bib0090","doi-asserted-by":"crossref","first-page":"427","DOI":"10.7326\/0003-4819-144-6-200603210-00010","article-title":"Evaluation of the quality of prognosis studies in systematic reviews","volume":"144","author":"Hayden","year":"2006","journal-title":"Ann. Intern. Med."},{"issue":"3","key":"10.1016\/j.critrevonc.2019.102818_bib0095","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s10120-013-0313-3","article-title":"Prognostic significance of miR-34a and its target proteins of FOXP1, p53, and BCL2 in gastric MALT lymphoma and DLBCL","volume":"17","author":"He","year":"2014","journal-title":"Gastric Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2019.102818_bib0100","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ajpath.2012.03.013","article-title":"Quantitative proteomics reveals that miR-155 regulates the PI3K-AKT pathway in diffuse large B-cell lymphoma","volume":"181","author":"Huang","year":"2012","journal-title":"Am. J. Pathol."},{"issue":"7","key":"10.1016\/j.critrevonc.2019.102818_bib0105","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1182\/blood-2014-04-566778","article-title":"Global microRNA expression profiling uncovers molecular markers for classification and prognosis in aggressive B-cell lymphoma","volume":"125","author":"Iqbal","year":"2015","journal-title":"Blood."},{"issue":"23","key":"10.1016\/j.critrevonc.2019.102818_bib0110","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1182\/blood.V126.23.2455.2455","article-title":"MiR-155 amplifies AKT and NFkB signaling by targeting multiple regulators of BCR signal in DLBCL","volume":"126","author":"Jablonska","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2019.102818_bib0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.critrevonc.2018.10.006","article-title":"Available prognostic models for risk stratification of diffuse large B cell lymphoma patients: a systematic review","volume":"133","author":"Jelicic","year":"2019","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"7","key":"10.1016\/j.critrevonc.2019.102818_bib0120","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1182\/blood-2006-07-025809","article-title":"Aberrant NF-kappa B signaling in lymphoma: mechanisms, consequences, and therapeutic implications","volume":"109","author":"Jost","year":"2007","journal-title":"Blood."},{"issue":"1","key":"10.1016\/j.critrevonc.2019.102818_bib0125","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1365-2141.2008.07424.x","article-title":"MicroRNA-155 expression and outcome in diffuse large B-cell lymphoma","volume":"144","author":"Jung","year":"2009","journal-title":"Br. J. Haematol."},{"issue":"10","key":"10.1016\/j.critrevonc.2019.102818_bib0130","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.3109\/07357907.2010.512596","article-title":"MiR-146b-5p suppresses EGFR expression and reduces in vitro migration and invasion of glioma","volume":"28","author":"Katakowski","year":"2010","journal-title":"Cancer Invest."},{"issue":"5","key":"10.1016\/j.critrevonc.2019.102818_bib0135","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1158\/1541-7786.MCR-13-0377","article-title":"PGE2-driven expression of c-Myc and OncomiR-17-92 contributes to apoptosis resistance in NSCLC","volume":"12","author":"Krysan","year":"2014","journal-title":"Mol. Cancer Res."},{"issue":"5","key":"10.1016\/j.critrevonc.2019.102818_bib0140","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/j.1365-2141.2008.07077.x","article-title":"Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma","volume":"141","author":"Lawrie","year":"2008","journal-title":"Br. J. Haematol."},{"issue":"12","key":"10.1016\/j.critrevonc.2019.102818_bib0145","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/s41408-017-0033-8","article-title":"MicroRNAs regulate key cell survival pathways and mediate chemosensitivity during progression of diffuse large B-cell lymphoma","volume":"7","author":"Leivonen","year":"2017","journal-title":"Blood Cancer J."},{"issue":"1","key":"10.1016\/j.critrevonc.2019.102818_bib0150","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1677\/ERC-10-0148","article-title":"The miR-200 family controls \u03b2-tubulin III expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patients","volume":"18","author":"Leskel\u00e4","year":"2011","journal-title":"Endocr. Relat. Cancer"},{"issue":"3","key":"10.1016\/j.critrevonc.2019.102818_bib0155","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.bbrc.2009.03.077","article-title":"MicroRNA-21 directly targets MARCKS and promotes apoptosis resistance and invasion in prostate cancer cells","volume":"383","author":"Li","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.critrevonc.2019.102818_bib0160","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13059-014-0568-y","article-title":"Comprehensive miRNA sequence analysis reveals survival differences in diffuse large B-cell lymphoma patients","volume":"16","author":"Lim","year":"2015","journal-title":"Genome Biol."},{"issue":"30","key":"10.1016\/j.critrevonc.2019.102818_bib0165","doi-asserted-by":"crossref","first-page":"29129","DOI":"10.18632\/oncotarget.4895","article-title":"miR-146b-5p functions as a tumor suppressor by targeting TRAF6 and predicts the prognosis of human gliomas","volume":"6","author":"Liu","year":"2015","journal-title":"Oncotarget."},{"issue":"11","key":"10.1016\/j.critrevonc.2019.102818_bib0170","first-page":"14875","article-title":"Evaluation of AKT phosphorylation and PTEN loss and their correlation with the resistance of rituximab in DLBCL. International journal of clinical and experimental pathology, 8(11), 14875","volume":"8","author":"Ma","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"16","key":"10.1016\/j.critrevonc.2019.102818_bib0175","doi-asserted-by":"crossref","first-page":"3754","DOI":"10.1182\/blood-2008-10-184077","article-title":"Differentiation stage\u2013specific expression of microRNAs in B lymphocytes and diffuse large B-cell lymphomas","volume":"113","author":"Malumbres","year":"2009","journal-title":"Blood."},{"issue":"1","key":"10.1016\/j.critrevonc.2019.102818_bib0180","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13046-018-0768-5","article-title":"Serum miR-22 as potential non-invasive predictor of poor clinical outcome in newly diagnosed, uniformly treated patients with diffuse large B-cell lymphoma: an explorative pilot study","volume":"37","author":"Marchesi","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"17","key":"10.1016\/j.critrevonc.2019.102818_bib0185","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1200\/JCO.2012.45.6228","article-title":"Clinical role of microRNAs in cytogenetically normal acute myeloid leukemia: miR-155 upregulation independently identifies high-risk patients","volume":"31","author":"Marcucci","year":"2013","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.critrevonc.2019.102818_bib0190","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.exphem.2015.12.007","article-title":"High miR-34a expression improves response to doxorubicin in diffuse large B-cell lymphoma","volume":"44","author":"Marques","year":"2016","journal-title":"Exp. Hematol."},{"issue":"2","key":"10.1016\/j.critrevonc.2019.102818_bib0195","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/ajh.24223","article-title":"Personalized risk prediction for event\u2010free survival at 24 months in patients with diffuse large B\u2010cell lymphoma","volume":"91","author":"Maurer","year":"2016","journal-title":"Am. J. Hematol."},{"issue":"1","key":"10.1016\/j.critrevonc.2019.102818_bib0200","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1373\/clinchem.2012.191502","article-title":"Downregulation and prognostic performance of microRNA 224 expression in prostate cancer","volume":"59","author":"Mavridis","year":"2013","journal-title":"Clin. Chem."},{"issue":"2","key":"10.1016\/j.critrevonc.2019.102818_bib0205","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.cell.2008.04.001","article-title":"miRiad roles for the miR-17-92 cluster in development and disease","volume":"133","author":"Mendell","year":"2008","journal-title":"Cell"},{"issue":"33","key":"10.1016\/j.critrevonc.2019.102818_bib0210","doi-asserted-by":"crossref","first-page":"13513","DOI":"10.1073\/pnas.0706217104","article-title":"A miR-24 microRNA binding-site polymorphism in dihydrofolate reductase gene leads to methotrexate resistance","volume":"104","author":"Mishra","year":"2007","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"12","key":"10.1016\/j.critrevonc.2019.102818_bib0215","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1038\/cdd.2013.125","article-title":"The miR-17\/92 cluster: a comprehensive update on its genomics, genetics, functions and increasingly important and numerous roles in health and disease","volume":"20","author":"Mogilyansky","year":"2013","journal-title":"Cell Death Differ."},{"issue":"9","key":"10.1016\/j.critrevonc.2019.102818_bib0220","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1093\/ptj\/89.9.873","article-title":"Reprint-preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"89","author":"Moher","year":"2009","journal-title":"Phys. Ther."},{"issue":"4","key":"10.1016\/j.critrevonc.2019.102818_bib0225","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1182\/blood-2010-11-321554","article-title":"miRNA expression in diffuse large B-cell lymphoma treated with chemoimmunotherapy","volume":"118","author":"Montes-Moreno","year":"2011","journal-title":"Blood."},{"issue":"4","key":"10.1016\/j.critrevonc.2019.102818_bib0230","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3109\/1354750X.2015.1068855","article-title":"Low expression of miRNA-224 predicts poor clinical outcome in diffuse large B-cell lymphoma treated with R-CHOP","volume":"20","author":"Ni","year":"2015","journal-title":"Biomarkers"},{"issue":"8","key":"10.1016\/j.critrevonc.2019.102818_bib0235","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/j.biocel.2010.03.004","article-title":"mir-17-92, a cluster of miRNAs in the midst of the cancer network","volume":"42","author":"Olive","year":"2010","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"14","key":"10.1016\/j.critrevonc.2019.102818_bib0240","doi-asserted-by":"crossref","first-page":"4761","DOI":"10.1158\/1078-0432.CCR-11-0494","article-title":"MicroRNA-146a downregulates NF\u03baB activity via targeting TRAF6 and functions as a tumor suppressor having strong prognostic implications in NK\/T cell lymphoma","volume":"17","author":"Paik","year":"2011","journal-title":"Clin. Cancer Res."},{"issue":"20","key":"10.1016\/j.critrevonc.2019.102818_bib0245","doi-asserted-by":"crossref","first-page":"8191","DOI":"10.1158\/0008-5472.CAN-08-1768","article-title":"Emerging role of miR-106b-25\/miR-17-92 clusters in the control of transforming growth factor beta signaling","volume":"68","author":"Petrocca","year":"2008","journal-title":"Cancer Res."},{"issue":"30","key":"10.1016\/j.critrevonc.2019.102818_bib0250","doi-asserted-by":"crossref","first-page":"12420","DOI":"10.1073\/pnas.1305656110","article-title":"PTEN loss defines a PI3K\/AKT pathway-dependent germinal center subtype of diffuse large B-cell lymphoma","volume":"110","author":"Pfeifer","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"10.1016\/j.critrevonc.2019.102818_bib0255","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1038\/leu.2011.305","article-title":"The miRNA-17\u223c 92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K\/AKT pathway activation","volume":"26","author":"Rao","year":"2012","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.critrevonc.2019.102818_bib0260","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/j.1365-2141.2008.07237.x","article-title":"MicroRNA signatures characterize diffuse large B\u2010cell lymphomas and follicular lymphomas","volume":"142","author":"Roehle","year":"2008","journal-title":"Br. J. Haematol."},{"issue":"7","key":"10.1016\/j.critrevonc.2019.102818_bib0265","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.3390\/ijms18071586","article-title":"The role of tumor microenvironment in chemoresistance: to survive, keep your enemies closer","volume":"18","author":"Senthebane","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.critrevonc.2019.102818_bib0270","doi-asserted-by":"crossref","first-page":"j4008","DOI":"10.1136\/bmj.j4008","article-title":"AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both","volume":"358","author":"Shea","year":"2017","journal-title":"Bmj"},{"issue":"6","key":"10.1016\/j.critrevonc.2019.102818_bib0275","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.leukres.2015.03.018","article-title":"MicroRNA signature is indicative of long term prognosis in diffuse large B-cell lymphoma","volume":"39","author":"Shepshelovich","year":"2015","journal-title":"Leuk. Res."},{"key":"10.1016\/j.critrevonc.2019.102818_bib0280","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.brainres.2010.07.009","article-title":"MiR-21 protected human glioblastoma U87MG cells from chemotherapeutic drug temozolomide induced apoptosis by decreasing Bax\/Bcl-2 ratio and caspase-3 activity","volume":"1352","author":"Shi","year":"2010","journal-title":"Brain Res."},{"issue":"10","key":"10.1016\/j.critrevonc.2019.102818_bib0285","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1007\/s00277-014-2111-3","article-title":"Serum microRNA expression profiling predict response to R-CHOP treatment in diffuse large B cell lymphoma patients","volume":"93","author":"Song","year":"2014","journal-title":"Ann. Hematol."},{"issue":"7","key":"10.1016\/j.critrevonc.2019.102818_bib0290","doi-asserted-by":"crossref","first-page":"659","DOI":"10.2174\/1568009614666140818211103","article-title":"Deregulated expression of miR-224 and its target gene: CD59 predicts outcome of diffuse large B-cell lymphoma patients treated with R-CHOP","volume":"4","author":"Song","year":"2014","journal-title":"Curr. Cancer Drug Targets"},{"issue":"4","key":"10.1016\/j.critrevonc.2019.102818_bib0295","doi-asserted-by":"crossref","first-page":"e347","DOI":"10.5301\/jbm.5000160","article-title":"High expression levels of miR-21 and miR-210 predict unfavorable survival in breast cancer: a systemic review and meta-analysis","volume":"30","author":"Tang","year":"2015","journal-title":"Int. J. Biol. Markers"},{"issue":"8","key":"10.1016\/j.critrevonc.2019.102818_bib0300","doi-asserted-by":"crossref","first-page":"18077","DOI":"10.3390\/ijms160818077","article-title":"miR-199a and miR-497 are associated with better overall survival due to increased chemosensitivity in diffuse large B-Cell lymphoma patients","volume":"16","author":"Troppan","year":"2015","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.critrevonc.2019.102818_bib0305","first-page":"557","article-title":"MicroRNAs in diffuse large B-cell lymphoma: implications for pathogenesis, diagnosis, prognosis and therapy","volume":"34","author":"Troppan","year":"2014","journal-title":"Anticancer Res."},{"issue":"2","key":"10.1016\/j.critrevonc.2019.102818_bib0310","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.bbrc.2014.04.095","article-title":"MiR-224 expression increases radiation sensitivity of glioblastoma cells","volume":"448","author":"Upraity","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"15","key":"10.1016\/j.critrevonc.2019.102818_bib0315","doi-asserted-by":"crossref","first-page":"6982","DOI":"10.1073\/pnas.1002472107","article-title":"Modulation of mismatch repair and genomic stability by miR-155","volume":"107","author":"Valeri","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"9","key":"10.1016\/j.critrevonc.2019.102818_bib0320","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1038\/cdd.2015.13","article-title":"The Fcp1-Wee1-Cdk1 axis affects spindle assembly checkpoint robustness and sensitivity to antimicrotubule cancer drugs","volume":"22","author":"Visconti","year":"2015","journal-title":"Cell Death Differ."},{"issue":"3","key":"10.1016\/j.critrevonc.2019.102818_bib0325","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.bbrc.2013.04.010","article-title":"MicroRNA-19a\/b regulates multidrug resistance in human gastric cancer cells by targeting PTEN. Biochemical and biophysical research communications, 434(3), 688","volume":"434","author":"Wang","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.critrevonc.2019.102818_bib0330","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.12659\/MSM.892096","article-title":"Prognostic role of microRNA-21 in gastric cancer: a meta-analysis","volume":"20","author":"Wang","year":"2014","journal-title":"Med Sci Monit."},{"issue":"8","key":"10.1016\/j.critrevonc.2019.102818_bib0335","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/jjco\/hyt084","article-title":"The prognostic value of miR-21 and miR-155 in non-small-cell lung cancer: a meta-analysis","volume":"43","author":"Wang","year":"2013","journal-title":"Jpn. J. Clin. Oncol."},{"issue":"12","key":"10.1016\/j.critrevonc.2019.102818_bib0340","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1038\/bjc.2014.551","article-title":"MiR-224 promotes the chemoresistance of human lung adenocarcinoma cells to cisplatin via regulating G1\/S transition and apoptosis by targeting p21WAF1\/CIP1","volume":"111","author":"Wang","year":"2014","journal-title":"Br. J. Cancer"},{"issue":"8","key":"10.1016\/j.critrevonc.2019.102818_bib0345","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1016\/j.humpath.2014.04.002","article-title":"Low expression of microRNA-146b-5p and microRNA-320d predicts poor outcome of large B-cell lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisone","volume":"45","author":"Wu","year":"2014","journal-title":"Hum. Pathol."},{"issue":"Suppl. 1","key":"10.1016\/j.critrevonc.2019.102818_bib0350","first-page":"5571","article-title":"Novel bio-markers latent membrane protein 1 and microRNA-155 for the prognostic prediction of diffuse large B cell lymphoma","volume":"130","author":"Wu","year":"2017","journal-title":"Hematology Am. Soc. Hematol. Educ. Program"},{"issue":"6","key":"10.1016\/j.critrevonc.2019.102818_bib0355","first-page":"9725","article-title":"Evaluation of latent membrane protein 1 and microRNA-155 for the prognostic prediction of diffuse large B cell lymphoma","volume":"15","author":"Wu","year":"2018","journal-title":"Oncol. Lett."},{"issue":"2","key":"10.1016\/j.critrevonc.2019.102818_bib0360","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/ijc.23501","article-title":"miR\u201015b and miR\u201016 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells","volume":"123","author":"Xia","year":"2008","journal-title":"Int. J. Cancer"},{"issue":"11","key":"10.1016\/j.critrevonc.2019.102818_bib0365","doi-asserted-by":"crossref","first-page":"e80426","DOI":"10.1371\/journal.pone.0080426","article-title":"Prognostic role of microRNA-21 in colorectal Cancer: a meta-analysis","volume":"8","author":"Xia","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.critrevonc.2019.102818_bib0370","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.3892\/or.2015.4497","article-title":"MicroRNA-30a downregulation contributes to chemoresistance of osteosarcoma cells through activating Beclin-1-mediated autophagy","volume":"35","author":"Xu","year":"2016","journal-title":"Oncol. Rep."},{"issue":"5","key":"10.1016\/j.critrevonc.2019.102818_bib0375","first-page":"269","article-title":"Significance of micro RNA-21 expression in diffuse large B-cell lymphoma (Chinese language)","volume":"21","author":"Yanan","year":"2012","journal-title":"J. Leuk. Lymphoma"},{"issue":"1","key":"10.1016\/j.critrevonc.2019.102818_bib0380","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s12967-018-1537-0","article-title":"Clinicopathologic implication of microRNA-197 in diffuse large B cell lymphoma","volume":"16","author":"Yang","year":"2018","journal-title":"J. Transl. Med."},{"issue":"3","key":"10.1016\/j.critrevonc.2019.102818_bib0385","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.ejca.2012.09.031","article-title":"High expression of miR-21 and miR-155 predicts recurrence and unfavourable survival in non-small cell lung cancer","volume":"49","author":"Yang","year":"2013","journal-title":"Eur. J. Cancer"},{"issue":"5944","key":"10.1016\/j.critrevonc.2019.102818_bib0390","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1126\/science.1175065","article-title":"The E3 ligase TRAF6 regulates akt ubiquitination and activation","volume":"325","author":"Yang","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.critrevonc.2019.102818_bib0395","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/hon.2072","article-title":"XIV. The rationale for combining targeted and biological anti-lymphoma drugs","volume":"31","author":"Younes","year":"2013","journal-title":"Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2019.102818_bib0400","doi-asserted-by":"crossref","first-page":"423","DOI":"10.3892\/ol.2015.3866","article-title":"Circulating microRNA-125b and microRNA-130a expression profiles predict chemoresistance to R-CHOP in diffuse large B-cell lymphoma patients","volume":"11","author":"Yuan","year":"2016","journal-title":"Oncol. Lett."},{"issue":"3","key":"10.1016\/j.critrevonc.2019.102818_bib0405","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.3892\/or.2014.3311","article-title":"Expression of miR-224-5p is associated with the original cisplatin resistance of ovarian papillary serous carcinoma","volume":"32","author":"Zhao","year":"2014","journal-title":"Oncol. Rep."},{"issue":"35","key":"10.1016\/j.critrevonc.2019.102818_bib0410","doi-asserted-by":"crossref","first-page":"59950","DOI":"10.18632\/oncotarget.19048","article-title":"The molecular mechanisms of chemoresistance in cancers","volume":"8","author":"Zheng","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.critrevonc.2019.102818_bib0415","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s13046-017-0551-z","article-title":"MiR21 sensitized B-lymphoma cells to ABT-199 via ICOS\/ICOSL-mediated interaction of Treg cells with endothelial cells","volume":"36","author":"Zheng","year":"2017","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.critrevonc.2019.102818_bib0420","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12943-019-0977-3","article-title":"MiR155 sensitized B-lymphoma cells to anti-PD-L1 antibody via PD-1\/PD-L1-mediated lymphoma cell interaction with CD8+ T cells","volume":"18","author":"Zheng","year":"2019","journal-title":"Mol. Cancer"},{"issue":"5","key":"10.1016\/j.critrevonc.2019.102818_bib0425","doi-asserted-by":"crossref","first-page":"763","DOI":"10.3892\/etm.2012.502","article-title":"Clinical and prognostic significance of miR-155 and miR-146a expression levels in formalin-fixed\/paraffin-embedded tissue of patients with diffuse large B-cell lymphoma","volume":"3","author":"Zhong","year":"2012","journal-title":"Exp. Ther. Med."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842819301908?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842819301908?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T19:32:04Z","timestamp":1760902324000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842819301908"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":85,"alternative-id":["S1040842819301908"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2019.102818","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical significance of aberrant microRNAs expression in predicting disease relapse\/refractoriness to treatment in diffuse large B-cell lymphoma: A meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2019.102818","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102818"}}